10 Apr 2019

Notice for Yellow Fever Vaccination Centres: Leaving the EU – yellow fever vaccine supply

NaTHNaC receives reassurance that contingencies for continuous yellow fever vaccine supply to the UK are robust and sustainable in the event of a ‘no deal’ EU Exit Notice for Yellow Fever Vaccination Centres: Leaving the EU – yellow fever vaccine supply

On behalf of Yellow Fever Vaccination Centres (YFVC) in England, Wales and Northern Ireland, NaTHNaC has been working closely with Sanofi Pasteur who manufacture, pack and supply yellow fever vaccine in France for the UK market. Sanofi Pasteur advises that their contingency plan for a ‘no deal’ EU Exit includes increasing yellow fever vaccine stock levels and securing alternative and robust supply lines into the UK.

Local stockpiling is unnecessary and YFVC should continue to order YF vaccine as usual.

Further updates will be provided when available.

Resources

COVID-19: advice for Humanitarian Aid workers

Advice for UK humanitarian aid workers deployed overseas during COVID-19 pandemic Read more

Umrah 2020/1442H: some restrictions eased for pilgrims

A staged approach to ease current restrictions is planned Read more

Resuscitation Council UK publish anaphylaxis guidance for vaccination providers

Updated information for health professionals involved in vaccination programmes Read more

Notice: Yellow Fever Vaccination Centres - Annual Return for YFVCs (1 January - 31 December 2020)

Information about the Annual Return for Yellow Fever Vaccination Centres (YFVCs) in England, Wales and Northern Ireland Read more

Coronavirus (COVID-19): cruise ship travel

Advice for travellers to who have booked or are planning a cruise ship holiday Read more
Back to Top

VIEW FULL INDEX